Most Popular White Papers
Content provided in partnership with
Health Care Industry
Industry: Email Alert RSS FeedAstraZeneca received FDA approval for Faslodex
Drug Store News, May 20, 2002 by Diane West, James Frederick
AstraZeneca received FDA approval for Faslodex (fulvestrant), a treatment for hormone receptor positive metastatic breast cancer in postmenopausal women whose cancer progresses despite treatment with anti-estrogen drugs, such as tamoxifen. The market for breast cancer drugs in the United States, according to AZ, is valued at more than $1 billion.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: News
Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »